Red light therapy for menopause symptoms

The menopause picture in the UK

Around 13 million women in the UK are currently perimenopausal or menopausal - roughly one in three of the female population. The average age of menopause here is 51, but perimenopause usually starts in the mid-to-late forties, and symptoms can arrive years before periods actually stop.

Hot flushes and night sweats affect 70-80% of women going through menopause. A 2022 Fawcett Society survey of over 4,000 women found 85% rated sleep disruption as very or somewhat difficult, and three quarters said brain fog meaningfully affected daily life. Joint pain, skin changes, mood shifts, fatigue, anxiety - these are not peripheral complaints. For many women they are the main event, and they persist for years.

HRT is the most effective treatment for many of these symptoms, and the conversation around it has shifted considerably. But around 50% of women in the UK go through menopause without ever consulting a medical professional - and many who do are looking for additional tools alongside or instead of hormonal options. That is what this article is about: what the research actually shows for red light therapy, symptom by symptom, with no padding around the uncertainty.

How red light therapy works - the relevant biology

Red light therapy delivers specific wavelengths of red and near-infrared light directly into tissue. It is not heat. It is not UV. The wavelengths are absorbed by cytochrome c oxidase (a light-sensitive protein inside the mitochondria - the cell's energy generators) which triggers a chain of biological responses.

For menopause specifically, two effects matter most: increased ATP production and reduced oxidative stress. ATP is the energy currency every cell runs on. Mitochondria under chronic oxidative stress produce less of it. Oestrogen normally helps keep mitochondrial function efficient - its decline during menopause directly reduces energy output across multiple tissue types at once. That is part of why menopause fatigue is systemic and persistent rather than ordinary tiredness.

Red light reactivates sluggish mitochondria. It does not restore oestrogen - nothing except hormonal treatment does that. What it does is act on the downstream effects of oestrogen withdrawal at a cellular level, which is why the right framing is a complementary tool, not a hormonal one.

Skin, collagen and dryness

Skin changes are often among the first visible signs of menopause. Women lose around 30% of their skin collagen in the first five years after menopause - that figure comes from the American Academy of Dermatology, and it explains a lot. Oestrogen activates fibroblasts, the dermal cells that produce collagen and elastin. When oestrogen drops, fibroblast activity slows, collagen breaks down faster than it is replaced, and the result is increased wrinkling, reduced firmness, skin thinning, and persistent dryness.

The evidence for red light here is among the strongest in the whole field. Red light is absorbed by mitochondria in dermal fibroblasts (the skin's collagen-producing cells) and increases their energy output, directly stimulating collagen and elastin production. It does this through a different pathway to oestrogen, but it targets the same cells. That is why this particular application translates well.

What the studies show

A 2014 randomised controlled trial by Wunsch and Matuschka (Photomedicine and Laser Surgery) enrolled 136 volunteers and used ultrasound imaging to measure collagen levels beneath the skin's surface. After 30 twice-weekly sessions, participants showed clear improvements in collagen density, skin roughness, and complexion quality compared to controls.

A 2023 trial by Couturaud et al. (Skin Research and Technology) applied red LED light daily for 84 days and found measurable reductions in pore size, wrinkle depth, and sebum (skin oiliness) - with histological analysis (tissue samples examined under a microscope) confirming that the dermis had physically thickened and collagen production had increased. Lab studies on human skin cells back this up: even low-level red and near-infrared exposure significantly boosts production of collagen, elastin, and hyaluronic acid.

Joint pain and inflammation

Joint pain is one of the most common and least talked-about menopause symptoms. Up to 50% of women in perimenopause or menopause experience new or worsening joint pain - hands, knees, hips, spine. Oestrogen is anti-inflammatory. It also helps maintain cartilage health. Lose it, and joints lose a layer of built-in protection. That can trigger or speed up degenerative changes and raise inflammatory markers that were previously kept in check.

This is not the same as arthritis, though menopause can accelerate its onset. Many women notice morning stiffness, aching that was not there before, and joints that feel less stable - without any obvious injury. The oestrogen link explains it.

What the studies show

Near-infrared has one of the stronger anti-inflammatory records in the photobiomodulation literature. A 2023 review by Zhang and Qu (International Journal of Molecular Sciences) found that near-infrared reduces inflammatory cytokines (the proteins that drive joint pain and swelling), calms synovial inflammation (irritation of the joint's inner lining), and shows evidence of cartilage repair in experimental models.

A 2024 umbrella review in EClinicalMedicine - synthesising multiple meta-analyses of randomised controlled trials - found moderate-certainty evidence for photobiomodulation reducing pain in knee osteoarthritis, rheumatoid arthritis, and fibromyalgia. These are conditions that disproportionately worsen around menopause.

A randomised placebo-controlled trial by Vassão et al. (Lasers in Medical Science, 2020) enrolled middle-aged and older women with knee osteoarthritis specifically. Women receiving active photobiomodulation showed clear reductions in pain scores compared to the placebo group.

Sleep and night sweats

Nearly 85% of menopausal women in the UK describe sleep disruption as very or somewhat difficult - and it is easy to see why it tops the list. Hot flushes and night sweats wake women physically. Declining oestrogen and progesterone alter sleep architecture directly. Mood changes make it harder to switch off. These do not operate independently; they stack.

Red light therapy works on sleep through two separate pathways: how it interacts with melatonin, and what improved cellular function does to the quality of sleep itself.

Light and melatonin

Blue and white light suppress melatonin. Red wavelengths do not. Some research suggests evening exposure to red light may actively support melatonin production by signalling to the nervous system that the environment is shifting toward rest. A 2023 randomised study by Pan et al. (Frontiers in Psychiatry) enrolled 114 participants including people with insomnia. Red light measurably changed sleep structure compared to white light and darkness - in ways consistent with falling asleep more easily.

A meta-analysis by van Maanen et al. analysed multiple trials of light therapy for sleep problems and found meaningful improvements in people with insomnia and those with disrupted body clocks - with effect sizes of g=0.47 for insomnia and g=0.41 for circadian disorders (scores above 0.4 are generally considered a clinically meaningful result).

Mood and brain fog

Anxiety, low mood, and cognitive changes - memory gaps, brain fog, difficulty concentrating - affect a large number of women in perimenopause and menopause, and they are not psychosomatic. Oestrogen directly influences serotonin, dopamine, and norepinephrine (the neurotransmitters that regulate mood and motivation). It also has a protective effect on the prefrontal cortex (the part of the brain responsible for memory, focus, and decision-making). When it drops, both mood and mental sharpness genuinely take a hit.

The evidence for photobiomodulation in this area is building, but it is not as far along as it is for skin or joints. Worth understanding, but worth being honest about.

Brain photobiomodulation

A 2019 meta-analysis by Salehpour et al. of all available studies on transcranial light therapy and cognition found a significant beneficial effect overall, concluding that photobiomodulation can act as a "cognitive-enhancing intervention in healthy individuals." Multiple controlled studies show that near-infrared applied transcranially (directed at the skull) improves cerebral blood flow (blood circulation to the brain) and produces measurable gains in working memory and executive function.

For mood, a systematic review designated red and near-infrared photobiomodulation as "strongly recommended" for moderate depression and "recommended" for anxiety - based on evidence of better cellular energy production, improved cerebral blood flow (circulation to the brain), and reduced neuroinflammation (inflammation in brain tissue). A 2009 clinical trial found measurable reductions in depression and anxiety symptoms after a single session.

Energy, fatigue and hair thinning

Menopause fatigue is not just tiredness. It is disrupted sleep compounding hormonal changes, compounding raised inflammation, compounding reduced mitochondrial efficiency across multiple tissue types. The result is an energy deficit that a good night's sleep does not fix - and often a sense of running at reduced capacity that feels physical, not just psychological.

Red light therapy's core mechanism - stimulating ATP production in mitochondria - addresses this directly. Every cell runs on ATP. When mitochondrial function degrades across the body simultaneously, the fatigue is systemic. Reactivating mitochondria is one of the most consistent and reproducible effects of photobiomodulation across the research literature.

Hair thinning - another complaint that often goes unaddressed - has decent evidence behind light therapy. Multiple clinical trials show improvements in hair density in androgenetic alopecia (hormonal hair loss - the most common type in menopause, where follicles progressively shrink and produce thinner, shorter hairs). The mechanism is the same: better ATP production (cellular energy) in the follicle extends the time hair spends in its active growth phase.

What red light therapy can and cannot do for menopause

There is real clinical support here across several areas. There is also a defined limit. Being clear about both matters more than either overselling or dismissing it.

How to use red light therapy for menopause symptoms

The clinical protocols are more consistent than the marketing around consumer devices suggests. Wavelength, irradiance, distance, session time, and frequency all matter - and the research is specific about them.

Wavelengths and what they reach

Irradiance, distance and session length

A quality panel delivers 80-120 mW/cm² (milliwatts per square centimetre - the standard measure of light output) at 15cm (six inches) from the skin. Sessions of 10-20 minutes at that distance hit clinically relevant energy doses. Three to five sessions per week is the frequency most consistently linked to positive outcomes in published research. Collagen remodelling takes weeks - trials showing visible skin improvements typically ran four to twelve weeks of consistent use.

Practical positioning